Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23398904 | 0.89 | NPC1 (0.34) | ADORA3ADORA2AADORA1 | |
| SCHEMBL23399803 | 0.85 | ADORA2A (0.33) | ADORA3ADORA2AADORA1 | |
| SCHEMBL23402687 | 0.79 | KDM4E (0.42) | ADORA2AADORA1 | |
| SCHEMBL23402399 | 0.75 | ACHE (0.36) | — | |
| SCHEMBL23403400 | 0.75 | C1S (0.33) | — | |
| SCHEMBL23403362 | 0.73 | HTT (0.40) | — | |
| SCHEMBL23401980 | 0.72 | L3MBTL1 (0.36) | — | |
| SCHEMBL23400652 | 0.70 | — | — | |
| SCHEMBL23400639 | 0.70 | ADORA2A (0.33) | ADORA3ADORA2AADORA1 | |
| SCHEMBL23398566 | 0.68 | ADORA2A (0.33) | ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-06-27 | — | — | US | disclosed |
| WO-2022223336-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2022-10-27 | — | — | WO | disclosed |
| EP-3828159-A1 | STORAGE AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS | BASF SE (DE) | 2021-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | CDK5, CABLES1, DPYD | ADORA3 4650/4885ADORA2A 4815/4885ADORA1 4677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.